English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Saturday, September 27, 2014
에스페리테, 중간엽 줄기세포로 뇌성마비 치료제 개발 계획
Esperite社R&D部門「セルファクトリー」がGMP準拠の幹細胞生物生産技術を導入、第1弾は脳性麻痺の臨床試験を目標
Esperite 的研發部“細胞工廠”實施 GMP 幹細胞生物生產技術並將腦性麻痺作為首批臨床試驗目標
Esperite 的研发部“细胞工厂”实施 GMP 干细胞生物生产技术并将脑性麻痹作为首批临床试验目标
Thursday, September 25, 2014
Esperite's R&D Division "The Cell Factory" implements GMP Stem Cell Bioproduction Technology and aims the Cerebral Palsy as first clinical trial

Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575